Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Affect Disord ; 128(1-2): 153-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20621361

ABSTRACT

OBJECTIVE: To examine the efficacy of adjunctive left prefrontal high-frequency rTMS treatment in depression patients as compared to sham stimulation. METHOD: 45 right handed moderate to severe depression patients according to ICD-10 DCR criteria were randomized to receive daily sessions of active or sham rTMS (10Hz, 90% of resting MT, 20 trains, 6s duration, 1200 pulses/day) over the right dorsolateral prefrontal cortex for 10 days. Depression and psychosis was rated using Structured Interview Guide for the Hamilton Depression Rating Scale (SIGH-D) and Brief Psychiatric Rating Scale (BPRS) respectively before and after rTMS. RESULT: For SIGH-D scores, repeated measures ANOVA showed a significant effect of treatment over time as shown by interaction effect (Pillai's Trace F [1/38] = 56.75, p<.001, η(2) = .60). For BPRS, repeated measures ANOVA showed a significant interaction effect of treatment over time (Pillai's Trace F [1/38] = 39.87, p<.001, η(2) = .51). In psychotic depression patients, repeated measures ANOVA showed a significant effect of treatment over time for SIGH-D scores (Pillai's Trace F [1/25] = 43.04, p<.001, η(2) = .63) and BPRS scores (Pillai's Trace F [1/25] = 42.17, p<.001, η(2) = .63). CONCLUSION: High-frequency left prefrontal rTMS was well tolerated and found to be effective as add-on to standard pharmacotherapy in nonpsychotic as well as psychotic depression.


Subject(s)
Depression/psychology , Depression/therapy , Prefrontal Cortex , Transcranial Magnetic Stimulation , Adolescent , Adult , Analysis of Variance , Depression/diagnosis , Female , Functional Laterality , Humans , International Classification of Diseases , Logistic Models , Male , Middle Aged , Prospective Studies , Psychiatric Status Rating Scales , Severity of Illness Index , Treatment Outcome , Young Adult
3.
Gen Hosp Psychiatry ; 31(4): 382-4, 2009.
Article in English | MEDLINE | ID: mdl-19555801

ABSTRACT

Hiccups can arise from idiopathic, psychogenic and organic causes. The use of therapeutic drugs forms one of the important causes of hiccups. Although the exact pathophysiological processes involved have not yet been established, the neurotransmitters dopamine, serotonin and gamma amino butyric aid (GABA) have been documented to play a significant role in the generation of hiccups. We report a patient of organic bipolar affective disorder who developed hiccups with the atypical antipsychotic aripiprazole. The possible underlying neurotransmitter mechanisms, predisposing factors and clinical implications of this rare adverse event are discussed.


Subject(s)
Antipsychotic Agents/adverse effects , Bipolar Disorder/drug therapy , Hiccup/chemically induced , Piperazines/adverse effects , Quinolones/adverse effects , Adult , Antimanic Agents/adverse effects , Antipsychotic Agents/metabolism , Aripiprazole , Bipolar Disorder/diagnosis , Bipolar Disorder/etiology , Bipolar Disorder/metabolism , Carbamazepine/adverse effects , Causality , Dopamine/physiology , Drug Interactions , Half-Life , Head Injuries, Closed/complications , Humans , Male , Piperazines/metabolism , Quinolones/metabolism , Receptors, Dopamine/drug effects , Receptors, Serotonin/drug effects , Serotonin/physiology , Time Factors , gamma-Aminobutyric Acid/drug effects , gamma-Aminobutyric Acid/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...